Aposave Rebrands to Abacus Medicine Pharma Services
Abacus Medicine Pharma Services (Farnborough, UK) is the new name for the healthcare and pharma services company previously known as Aposave.
The rebrand reflects the company’s plans to access to the US and Chinese markets.
Through its parallel distribution division, the organization has been providing access to pharmaceutical products and healthcare to Europeans for almost 20 years. In order to establish a global footprint, the group — which has three service lines: Clinical Trial Solutions, Commercial Partnerships and Unlicensed Medicines — established a full healthcare and pharma services division with commercial headquarters in the UK in 2020. Today, it has companies in the US, UK, Denmark, Hong Kong and The Netherlands.
“We made an excellent start as Aposave and now as Abacus Medicine Pharma Services we plan to make significant strides forward,” commented managing director Simon Estcourt.
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Racial, Social, and Economic Factors Drive Resilience During COVID-19 Pandemic, Study Finds
July 18th 2025The study reveals that resilience varies significantly by race, education, income, and insurance status, highlighting the role of social determinants and systemic inequities in shaping health outcomes.
Thermo Fisher, Sanofi Expand Partnership to Boost Sterile Drug Production
July 16th 2025Per the deal, Thermo Fisher will acquire Sanofi’s sterile drug product manufacturing facility in Ridgefield, NJ, to support production of Sanofi therapies and expand capacity for US-based pharma and biotech manufacturing.
